Zymeworks Enters its First ZymeLink TM Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics

Wednesday, May 15, 2019 1 min read

Key Takeaway: Zymeworks Enters its First ZymeLink TM Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics

Full Press Release Details

Zymeworks Enters its First ZymeLink TM Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics.